Evaluation and Management Approach
This patient has anemia of chronic disease (ACD) with macrocytosis, not iron deficiency anemia, and requires immediate investigation for the underlying chronic inflammatory condition causing hypoalbuminemia, hypocalcemia, and electrolyte abnormalities—not iron supplementation.
Critical Laboratory Pattern Recognition
This patient presents with a constellation of findings that point away from simple iron deficiency:
- Elevated ferritin (421.2 ng/mL) with low iron (45.7 μg/dL) and low TIBC (120.7 μg/dL) = classic anemia of chronic disease pattern 1, 2
- Macrocytic anemia (MCV 107.4 fL) with hemoglobin 9.8 g/dL—this is NOT iron deficiency anemia, which causes microcytosis
- Low total protein (4.6 g/dL) and albumin (2.5 g/dL) = severe protein loss or malnutrition
- Low free T4 (0.59 ng/dL) with normal TSH = possible sick euthyroid syndrome from chronic illness
- Low calcium (7.9 mg/dL) = likely related to hypoalbuminemia (corrected calcium may be normal)
Why This Is NOT Iron Deficiency Anemia
The ferritin of 421.2 ng/mL definitively excludes absolute iron deficiency. According to British Society of Gastroenterology guidelines, ferritin >150 μg/L is unlikely to occur with absolute iron deficiency, even in the presence of inflammation 3. The low iron and low TIBC indicate functional iron deficiency within the context of chronic disease, where iron is sequestered in macrophages by hepcidin 1, 2.
The macrocytic pattern (MCV 107.4) further confirms this is not iron deficiency, which causes microcytosis 3. The macrocytosis here may reflect chronic disease, medication effects (naproxen can affect red cell parameters), or nutritional deficiencies (B12/folate).
Immediate Diagnostic Priorities
1. Identify the Underlying Chronic Disease
The severe hypoalbuminemia (2.5 g/dL) and low total protein demand urgent investigation for:
- Protein-losing enteropathy: Check stool alpha-1 antitrypsin
- Nephrotic syndrome: Urinalysis already done—review for proteinuria
- Chronic liver disease: AST/ALT are actually LOW (AST 10, ALT 6), which is unusual and may indicate severe malnutrition
- Malignancy: Consider serum protein electrophoresis and immunofixation to exclude plasma cell disorders or lymphoproliferative disease 4
- Malabsorption syndromes:
2. Evaluate Macrocytosis
- Check vitamin B12 and folate levels immediately
- Consider methylmalonic acid and homocysteine if B12 is borderline 6
- Review medication list beyond naproxen for drugs causing macrocytosis
- Reticulocyte count is needed to assess bone marrow response
3. Correct Electrolyte Abnormalities
- Hypokalemia (3.4 mmol/L): Replete potassium, especially if patient has cardiac risk factors
- Hypocalcemia (7.9 mg/dL): Calculate corrected calcium for albumin. Formula: Corrected Ca = measured Ca + 0.8 × (4.0 - albumin). With albumin 2.5, corrected calcium ≈ 9.1 mg/dL (likely normal)
- If corrected calcium remains low, check PTH, vitamin D, magnesium
4. Thyroid Function
Low free T4 with normal TSH suggests sick euthyroid syndrome (non-thyroidal illness syndrome) from chronic disease rather than primary hypothyroidism. Repeat thyroid function tests after treating underlying condition. Do not start thyroid replacement based on these results alone.
Management Algorithm
Step 1: Stop Unnecessary Medications
- Discontinue naproxen 7. The FDA label notes that NSAIDs can cause:
- Anemia through GI blood loss or effects on erythropoiesis
- Fluid retention affecting hemoglobin concentration
- Hepatotoxicity (though this patient has low transaminases)
- The note about spurious bilirubin elevation with naproxen is present in the labs
Step 2: Nutritional Assessment and Repletion
- Nutritional consultation for severe hypoalbuminemia 5
- High-protein diet if oral intake adequate
- Consider enteral nutrition if malabsorption identified
- Replete B12/folate if deficient
Step 3: DO NOT Give Oral Iron
This patient does NOT need oral iron supplementation. The elevated ferritin indicates adequate iron stores that are functionally unavailable due to hepcidin-mediated sequestration 1, 2. Oral iron will not be absorbed effectively and may cause GI side effects.
Step 4: Consider IV Iron ONLY After Diagnosis
If the underlying chronic disease is identified and treated, and anemia persists with evidence of functional iron deficiency (transferrin saturation 37.86% is borderline), IV iron may overcome hepcidin blockade 5, 2. However, this should be deferred until:
- The primary disease process is identified
- Nutritional deficiencies are corrected
- The patient is not actively inflamed
Step 5: Erythropoiesis-Stimulating Agents (ESAs)
Consider ESAs only if:
- Underlying disease is treated or untreatable
- Hemoglobin remains <10 g/dL
- Quality of life is significantly impaired
- Used in combination with IV iron if functional iron deficiency persists 1, 2
Critical Pitfalls to Avoid
- Do not treat this as simple iron deficiency anemia based on low iron alone—the elevated ferritin and macrocytosis exclude this diagnosis
- Do not give oral iron empirically—it will not work and delays proper diagnosis
- Do not ignore the severe hypoalbuminemia—this is the key to finding the underlying disease
- Do not start thyroid replacement for sick euthyroid syndrome
- Do not perform GI endoscopy for "iron deficiency" until you confirm actual iron deficiency (ferritin <45 μg/L) 3, 5
Monitoring Parameters
- Repeat CBC with reticulocyte count in 2-4 weeks
- Albumin and total protein weekly until stable
- Electrolytes within 3-5 days after repletion
- Thyroid function after treating underlying disease
- Ferritin and iron studies only after inflammation resolves
The priority is diagnosing the chronic disease causing protein loss and inflammation, not treating anemia in isolation.